Australian company acquires novel anti-cancer drug technology
Sydney-headquartered life science group, the IQ Group Global, has announced the acquisition of an anti-cancer drug platform from the University of Texas, and plans to begin clinical trials of novel platinum-based chemotherapy drugs within the next 12 months.
Details